Pulverzed crystals of olmesartan medoxomil
AssigneeDaiichi Sankyo Company, Limited
InventorsSusumu Hasegawa, Takeshi Hamaura
Life of this patent
Estimating the term…
Abstract
An olmesartan medoxomil having a particle diameter at 90% cumulative volume of 75 μm or less, which provides an improved dissolution property. The olmesartan medoxomil is advantageously used to treat or prevent hypertension or a disease caused by hypertension.
Claims9
An olmesartan medoxomil having a particle diameter at 90% cumulative volume of 75 μm or less.
An olmesartan medoxomil having a particle diameter at 90% cumulative volume of 66 μm or less.
An olmesartan medoxomil having a particle diameter at 90% cumulative volume of 57 μm or less.
An olmesartan medoxomil having a particle diameter at 90% cumulative volume of 75 μm or less and a particle diameter at 99% cumulative volume of 156 μm or less.
An olmesartan medoxomil having a particle diameter at 90% cumulative volume of 66 μm or less and a particle diameter at 99% cumulative volume of 137 μm or less.
An olmesartan medoxomil having a particle diameter at 90% cumulative volume of 57 μm or less and a particle diameter at 99% cumulative volume of 119 μm or less.
Dependencies are inferred from the claim text.